NEOANTIGENICS, INC.

Profile

Company Names

NEOANTIGENICS, INC.
NEOANTIGENICS, LLC

Addresses

1000 RESEARCH PARK BLVD., SUITE 103, CHARLOTTESVILLE, VA 22911

Phone Numbers

(434) 984-9723

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

VIRGINIA

Total Amount Raised:

$3,137,913.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2015-02-12 
$3,025,713.00 
$3,025,713.00 
$0.00 
Equity 
1
2013-10-21 
$112,200.00 
$1,100,000.00 
$987,800.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED 
 
ESHELMAN 
DIRECTOR
XORI CORP   |  CORINTHIAN OPHTHALMIC, INC.   |  MERYX INC.   |  NEOANTIGENICS, INC.   |  DIGNIFY THERAPEUTICS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  ASEPTICYS, INC.   |  EYENOVIA, INC.   |  ASEPTICYS, LLC
JOHN 
C. 
HERR 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEOANTIGENICS, LLC   |  NEOANTIGENICS, INC.
EDWARD 
J. 
LEARY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEOANTIGENICS, LLC   |  NEOANTIGENICS, INC.
BRIAN 
A. 
POLLOK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEOANTIGENICS, LLC   |  NEOANTIGENICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-12 
2013-10-22
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-10-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#